Related Experiment Video
Updated: Sep 13, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Progress of antibiotic therapy in pediatrics]
1Universitäts-Kinderklinik, Kiel, Germany.
Insights
Advances in antibiotic therapy significantly reduced childhood fatalities from bacterial infections like pneumonia and sepsis. New antibiotic combinations, such as cefotaxime plus piperacillin, proved highly effective in preventing and treating severe infections in pediatric intensive care units.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Pharmacology
- Epidemiology
Context:
- Acute bacterial infections pose significant risks to children, including pneumonia and sepsis.
- Historically, complications and fatalities from these infections were high.
- Advances in antibiotic therapy have aimed to mitigate these risks.
Purpose:
- To evaluate the impact of evolving antibiotic therapies on pediatric infection rates and outcomes.
- To assess the efficacy of specific antibiotic regimens in reducing complications and mortality.
- To analyze trends in childhood mortality related to bacterial infections over time.
Summary:
- Childhood mortality from pneumonia decreased significantly between 1954-1958 and 1969-1973.
- Infections following surgery for congenital heart disease dropped from 17.8% to 3.6% with updated antibiotic prophylaxis (cefotaxime plus piperacillin).
- Sepsis incidence in a pediatric intensive care unit was 5%, with a 2% mortality rate when treated with cefotaxime plus piperacillin, which also prevented sepsis development.
Impact:
- Improved antibiotic strategies have led to a marked decline in childhood deaths due to bacterial infections.
- The use of broad-spectrum antibiotics like cefotaxime plus piperacillin has enhanced patient safety in pediatric surgery and intensive care.
- These findings underscore the critical role of timely and effective antibiotic treatment in pediatric critical care settings.
Abstract:
The advances in the antibiotic therapy of acute bacterial infections can be shown by the decreasing frequency of complications and fatalities in children. The annual death-rate from pneumonia in children aged one month to 15 years has fallen in Schleswig-Holstein from 1.8 (1954-1958) to 0.6 per 10,000 (1969-1973). At the same time the total death-rate in the same age group has fallen from 14.5 to 9.3 per 10,000 children. The percentage of pneumonia in the total death-rate was 5.3% in 1971-1973: 1.6% in the first month of life and after the sixteenth year 2.3%. Pneumonia was in fourth place (after accident, malformation and neoplasm) as a cause of death in children more than one month old. Of 245 children operated on for congenital heart disease in 1983-1984, bacterial and fungal infections occurred in 3.6% compared to 17.8% of 469 in 1968-1972. Staphylococcal infections decreased from 3.4% to 0.8% and those caused by gram-negative bacteria from 6.9% to 0. Perioperative prophylaxis was performed with cefotaxime plus piperacillin in 1983-1984 versus oxacillin plus ampicillin in 1968-1972. Between 1984 and 1989, 944 children (premature babies and term babies) were treated in the intensive care unit of the University Children's Hospital of Kiel. The incidence of sepsis was 5% (congenital sepsis 4%, sepsis acquired after birth 1%). Early diagnosis and treatment of severe bacterial infections with cefotaxime plus piperacillin reduced the mortality rate of sepsis to 2%. Sepsis never developed under treatment with cefotaxime plus piperacillin.(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management

